Spots Global Cancer Trial Database for The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
Official Title:
Study ID: NCT02327819
Conditions
Study Description
Brief Summary: Supplementation of BCAA found to reduce the risk of developing liver cancer, but the affect of BCAA on existing liver cancer is unknown. The participants (post curative intent surgery) will be supplemented with either BCAA/non-BCAA-enriched protein supplement. The intervantion will go on for 2 years or until a new liver tumor is found.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Clinical Nutrition Unit, Sourasky Medical Center, Tel Aviv, , Israel
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
